Introduction
Deletions of the short arm of chromosome 12 are rare with only thirteen patients reported since the first description of an infant carrying the deletion 12p11p13 in 1975 (Bahring et al., 1997; Boilly-Dartigalongue et al., 1985; Fryns et al., 1990; Glaser et al., 2003; Lu et al., 2009; Macdonald et al., 2010; Magenis et al., 1981; Magnelli and Therman, 1975; Malpuech G et al., 1975; Nagai et al., 1995; Orye and Craen, 1975; Soysal et al., 2011; Stumm et al., 2007; Tenconi et al., 1975) . A number of common features of patients with interstitial 12p deletions have emerged including global delay, cardiac anomalies (AVSD, VSD, ASD II), microcephaly, and optic nerve atrophy (Table 1) . Still, the spectrum of the clinical phenotype remains unknown. Here, we describe a boy with a de novo interstitial deletion of chromosome 12. We characterized the extent of the deletion by array CGH and compared the phenotypic characteristics of the patient with those of previously published case studies.
Material and methods

Karyotype
For chromosome analysis peripheral blood lymphocytes from the index patient, his brother, and his parents were karyotyped using standard protocols for cultivation and GTG banding at a level of 550 bands in accordance with the International System for Human Cytogenetic Nomenclature (ISCN) (Mitelman, 1995) .
Array CGH analysis
We obtained blood samples from the index patient and his parents after written informed consent. Genomic DNA was isolated from peripheral blood lymphocytes according to standard procedures. Patient and female reference DNA (Promega, Mannheim, Germany) were labeled with Cy3 and Cy5 using the Genomic DNA Enzymatic Labeling Kit (Agilent, Santa Clara, CA) according to the manufacturer's protocol. The mixture was hybridized on a 180 K oligonucleotide array (Agilent, Santa Clara, CA) for 16 h in a hybridization oven. Image data were analyzed using Feature Extraction 9.5.3.1 and CGH Analytics 3.4.40 software (Agilent Technologies, Santa Clara, CA) with the following analysis settings: aberration algorithm ADM-2; threshold: 6.0; window size: 0.2 Mb; filter: 5 probes, log2ratio = 0.29. Genome coordinates are shown according to human genome build GRCh37(hg18).
Results
Phenotype
The boy is the second child of non-consanguineous and healthy parents of German descent (Fig. 1A) . His mother reported two previous miscarriages and unilateral ear fistulas of two maternal half siblings. The index patient was born at term following an uneventful pregnancy without complications: birth weight 3390 g (40th centile; −0.22 SD), length 50 cm (35th centile; 0 SD), occipitofrontal head circumference (OFC) 34 cm (15th centile; −0.79 SD). He was first presented at 4 weeks-of-age for cyanotic spells, an eye movement disorder of intermittent exotropia and discrete anisocoria. At that time, a small persistent ductus arteriosus was diagnosed. At an age of eight months, he presented at our hospital because of a respiratory syncytial virus (RSV) bronchiolitis and an anal herpex simplex virus (HSV) 1 infection. On clinical investigation, he had significant psychomotor delay. Griffith testing revealed a developmental age of 10.5 months at the chronological age of 23.5 months (developmental quotient b 45%). Facial dysmorphism was noted i.e. small ears, epicanthus, broad nasal bridge, and hypoplastic nostrils (Fig. 1B, Supplemental Fig. 1 ). In addition, the patient showed a dystrophic growth at the age of 16 months: height 75.5 cm (0.5 cm b3rd centile, −1.48 SD), weight 9.78 kg (10th centile, −1.40 SD), a postnatal (secondary) microcephaly (OFC 44.4 cm (1 cm b 3rd centile, −2.31 SD)) ( Fig. 1C) , inverted nipples, a micropenis, a hemangioma on his lower extremities ( Fig. 1B) and trunk hypotonia. Results of routine laboratory tests, metabolic screening, electroencephalogram (EEG) and echocardiogram were normal. No seizures were reported. The patient had a normal bone age shown by X-ray without signs of brachydactyly type E and normotensive blood pressure values. Abdominal ultrasound revealed mild splenomegaly. VEP and cranial MRI showed evidence of bilateral optic atrophy (Fig. 1D ). Radiation-induced chromosome fragility was increased significantly at 1.0 Gy, although not as high as in patients with ataxia telangiectatica or Nijmegen breakage syndrome. This region contains more than 40 known genes (Table 2 ) and extends from position 20.48 Mb to 30.01 Mb (Fig. 2) . The patient's mother and brother showed a karyotype with a balanced Robertsonian translocation between chromosome 13 and 15.
Discussion
We report a patient with a de novo 9.2 Mb interstitial deletion on the short arm of chromosome 12 (12p12.2-p11.22) encompassing more than 40 reference genes. So far, ten other cases with interstitial deletions of the proximal part of chromosome 12 have been described (Bahring et al., 1997; Boilly-Dartigalongue et al., 1985; Glaser et al., 2003; Lu et al., 2009; Magenis et al., 1981; Malpuech G et al., 1975; Nagai et al., 1995; Orye and Craen, 1975; Soysal et al., 2011) and three patients with deletions extending more distally (Fryns et al., 1990; Lu et al., 2009; Tenconi et al., 1975) . In the DECIPHER database (http://decipher.sanger.ac.uk) three additional cases with deletion 12p have been described (Table 1) . When comparing the phenotype of the previously described cases with that of our patient, there is an overlap of clinical signs and symptoms such as psychomotor delay, microcephaly, facial dysmorphism including a flat nasal bridge and small ears, and ocular anomalies, particularly strabismus and bilateral optic nerve atrophy. These latter clinical signs and symptoms are unspecific and can be observed in association with various other chromosomal aberrations. We did not detect a correlation between the 12p deletion size or location and the clinical symptoms in the known cases including our index patient (Table 1, Fig. 3 ). Features reported previously in association with a 12p deletion but not present in our index patient were thoracic dystrophy, hair and skin changes, dental or skeletal anomalies, and borderline high blood pressure.
Malignancies
A putative increased risk for development of malignancies exists in view of the oncogenes and tumor suppressor genes within the deleted region of 12p in our index patient (Table 2 ). These genes are: KRAS (Kirsten rat sarcoma viral oncogene homolog, OMIM*190070), which regulates homeostasis and tumorgenesis in the colon (Haigis et al., 2008) and has been identified to hold mutations in patients with Noonan syndrome (OMIM#609942). RECQL (OMIM*600537), encoding for DNA repair helicase, plays a role in chromosome fragility. Mutations in similar genes such as RECQL2/3 cause autosomal recessive Bloom Syndrome (OMIM#210900) and Werner Syndrome (OMIM#2777700). Moreover, CASC1 (cancer susceptibility candidate 1) polymorphisms have been described in several tumors, especially in lung cancer (Liu et al., 2003) . Furthermore, there are a few in vitro data showing the importance of RASSF8 (OMIM#608231) for mitosis (Falvella et al., 2006; Lock et al., 2010; Sherwood et al., 2009) . FGFR1OP2 (OMIM*608858) plays a role in the pathogenesis of myeloproliferative syndrome (Grand et al., 2004) . STK38L is expressed in the process of squamous cell cancer development (Hummerich et al., 2006) . ERGIC2 (OMIM*612236) encodes a ubiquitously expressed nuclear protein that is down-regulated in prostate carcinoma (Liu et al., 2003) . In addition, the short arm of chromosome 12 has been found to rearrange in a wide spectrum of leukemic cells. In a subgroup of hematologic malignancies, multiple chromosomal breaks in the 12p12 to p13 region result in the formation of rearrangements including translocations, inversion, and deletions (Sato et al., 2001) . So far no malignancies have been reported in patients with 12p deletions. However, the reported children are very young, and we propose a long-term follow-up and analysis of chromosome instability in all cases.
Microcephaly
Eight of the reported thirteen patients in Table 1 presented with microcephaly, a clinical finding also present in our patient. This finding may be explained through a deletion of genes with an important role in the cerebral development but the case of Magenis et al. (1981) also showed microcephaly and this does not overlap with the deleted region in our index patient (Fig. 3) . In our patient the mentioned genes could be responsible for microcephaly. One such gene is sarcospan SSPN (OMIM*601599; Kras oncogeneassociated gene), a gene that encodes a dystrophin-glycoprotein complex (DGC) member and plays a role in hypoxia induced glial cell death (Zhou et al., 2008) . Further genes to consider are the serine/threonine kinase 38 like, important for cell cycle and apoptosis gene STK38L (Cornils et al., 2011; Vichalkovski et al., 2008) and the SOX5 gene (OMIM*604975, sex determining region Y-box 5). SOX genes are, in general, important for cell proliferation (Dugas et al., 2010) , and SOX5 is, in particular, important for central nervous system development including oligodendrocyte differentiation and migration (Rosenfeld et al., 2010) . Indeed, microcephaly is a recurrent feature in patients with 12p deletion but as mentioned above this can also be nonspecific. So far, none of the authors of other case reports specified the head circumference development. Postnatal microcephaly, as detected in our patient, could be secondary to apoptosis, as the patient did not display any evidence of a myelination disorder. It would be of interest to also differentiate between primary and secondary microcephaly in future reports.
Cardiovascular abnormalities
Four of the reported 13 patients display cardiovascular abnormalities not present in our patient, who only had a small PDA (persistent ductus arteriosus). There are two reference genes in the deleted region known to be associated with cardiovascular disorders: heterozygous mutations in ABCC9 (ATP-binding cassette, sub-family C member 9; OMIM*601439) cause dilated cardiomyopathy (Bienengraeber et al., 2004) , and heterozygous deletions of PTHLH (OMIM+168470) can cause brachydactyly type E (OMIM#613382) and can be associated with arterial hypertension (Klopocki et al., 2010) . Therefore, patients with deletion 12p need to be screened for abnormal blood pressure and pathological echocardiogram.
Microdeletion 12p
Analysis of G-banded metaphase chromosomes from the patient showed the presence of an interstitial deletion of the short arm of chromosome 12: karyotype 46XY, del(12)(p11.2p12.2). We performed array-CGH analysis to refine the extent of the deletion. This revealed a de novo interstitial deletion of 9.2 Mb in the 12p12. 2-p11.22 region (chr12: 20,842,661-661-30,015,311, hg18) , which contains more than 40 known genes (Table 2 ) and extends from position 20.48 Mb to 30.01 Mb (Fig. 2) . The deletions of previously examined patients were determined merely by G-banding analysis. In the present study, we determined the extent of the deletion of our patient by array CGH to encompass about 9.2 Mb. It is a future task of clinical cytogenetics to more precisely characterize structural aberrations in order to define more clearly the cases with similar imbalances, which then can be studied with respect to phenotype and clinical variability. With our case report, we contribute to the understanding of the phenotype of patients with interstitial deletions of chromosome 12p. Knowledge of the pattern of this deletion-phenotype will help clinicians to diagnose this abnormality in their patients and to counsel the parents accordingly. Further descriptions may be able to contribute to the clarification.
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.mgene.2013.10.014.
